Adams Rounds Out Mucinex Brand With Line Extension Approval
This article was originally published in The Tan Sheet
Executive Summary
FDA approval of Adams Respiratory Therapeutics' Mucinex D gives the firm another brand line extension to compete in the crowded OTC cough/cold market